Journal of Clinical Lipidology

Article	Citations
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia	102
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers	96
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State	93
News from NLA	84
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine	54
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database	53
The Effect of Estrogen and Testosterone on Cholesterol Crystallization	51
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease	48
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice	46
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes	45
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis	41
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma	39
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis	39
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia	38
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	36
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss	32
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	31
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection	30
Achievement of Low-Density Lipoprotein Cholesterol Thresholds in Very High-Risk Atherosclerotic Cardiovascular Disease	29
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse	29
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	28
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report	27
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the Americ	25
Table of Contents	25
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	25

Use of lipid-lowering therapies in patients with CKD and ASCVD: A 1-year update from GOULD	23
Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study	21
*Real-World Experience with Inclisiran at a Large Academic Lipid Clinic	20
Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands	20
News from the NLA	19
From the Editors: Familial hypercholesterolemia: Still underdiagnosed and undertreated	19
The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study	18
Unique Case of Management of Severe Hypertriglyceridemia Secondary to Familial Chylomicronemia Syndrome	18
The Healthy Eating Assessment Tool (HEAT): A Aimplified 10-Point Assessment of CHILD-2 Dietary Compliance for Children with Dyslipidemia	18
Characterization of Inclisiran Use in Real World: Prescription Data from Germany	18
⁎ Incidental Coronary Calcium on Non-Gated CT Scans of the Chest: A Stepwise Approach to Addressing Underreporting and Implementing Deep Learning	18
The recognition and appreciation of Familial Hypercholesterolemia among Internal Medicine residents in the United States	18
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk	17
Safety and effectiveness of evinacumab in an infant with homozygous familial hypercholesterolemia: A new renaissance for the very young?	17
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia	17
Overcoming the real and imagined barriers to cholesterol screening in pediatrics	17
Triglyceride-rich lipoprotein sphingolipids are altered in primary hypertension: A pilot case-control study	17
Lipid profile and risk factors for neoatherosclerosis after drug-eluting stent implantation in acute coronary syndrome	17
Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency	17
Editorial Board	16
Association of cumulative low-density lipoprotein cholesterol exposure with vascular function	16
Characteristics Associated with Inclisiran Initiation in Outpatient Physician Clinics	16
Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis	15
A Machine-Learning Algorithm using Claims Data to Identify Patients with Homozygous Familial Hypercholesterolemia (HoFH)	14
*An Unsolved Case: FH or Sitosterolemia?	14
Management of Atherogenic Dyslipidemia in a Patient with LDL Discordance	14
†Safety and Efficacy of Bempedoic Acid in Patients with Hypertension	14
Disparities Among Gender and Racial Groups in the Achievement of Optimal Lipid Levels in Patients Following Acute Coronary Syndrome	13
Screening for Familial Hypercholesterolemia using Epic Secure Chat in Comparison to Epic Letter as Educational Outreach˄	13
Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease	13
Marked Hypoleptinemia precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy	13
Comprehensive assessment of the combined impact of dyslipidemia and inflammation on chronic kidney disease development: A prospective cohort study	13
†Cardiovascular Trials Over the Last 15 years: Analysis of the Characteristics and Trends of ClinicalTrials.gov Listings from 2008 to 2022	12
Tailored Therapeutic Strategies for the Management of Chylomicronemia Syndrome	12
The Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Program and Collaborative Learning Network (CL	12
Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases	12
The causal association between lipid-lowering strategies and risk of intracranial aneurysms: A drug-target Mendelian randomization study	11
Genetic Testing Results in a Preventative Cardiology and Inherited Lipid Disorders Clinic	11
Hypertriglyceridemia induced Pancreatitis is associated with lower Inpatient Morbidity and Mortality compared to Biliary Pancreatitis	11
Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) – Results of a US national survey	11
Carotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients	11
Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes	11
From the editors: Upcoming treatments for familial chylomicronemia syndrome: Agents that inhibit production of apolipoprotein CIII	11
Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size	11
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice	11
Accelerated Atherosclerosis in a Patient With Multifactorial Chylomicronemia Syndrome (MCS), Elevated Lp(a), APOE2/4 Genotype and Diabetes Mellitus.	10
Why Are Patients Presenting with STEMI Already on Statin Not Treated with Additional Aggressive Lipid-lowering Agents?	10
Habitual fish oil supplementation, genetic susceptibility of kidney stones and the risk of new-onset kidney stones	10
IS TANGIER DISEASE A RARE CAUSE OF PREMATURE OVARIAN INSUFFICIENCY? – A CASE REPORT	10
†Utility of AI-QCPA: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated with Quantified Plaque Analysis	10

Racial Disparities and Modifiable Risk Factors in Black Patients with Familial Hypercholesterolemia	10
Time to benefit of intensive lipid lowering therapy in individuals with cardiovascular disease	9
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia	9
Hourly 4-minute walking breaks from sitting following aerobic exercise reduce postprandial non-HDL cholesterol in healthy young adults - A randomized crossover trial	9
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America	9
Concordance between LDL-C estimated by various formulas and directly measured LDL-C	9
Functional profiling of LDLR variants: Important evidence for variant classification	9
Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction	9
Clinical impact of ≥50% reduction of low density lipoprotein cholesterol following lipid lowering therapy on cardiovascular outcomes in patients with acute coronary syndrome	9
Persistent hypercholesterolemia in child with homozygous autosomal recessive hypercholesterolemia: A decade of lipid management	9
Elevated Levels of Lp(a) are Associated with Circulating Levels of PCSK9 and Coronary Atherosclerosis as Detected by Cardiac Computed Tomography Angiography	9
Multidisciplinary Management of Lipoprotein X-Induced Hyperlipidemia Secondary to Drug-Induced Liver Injury	9
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis	9
Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study	9
Cardiovascular Mortality and Hospitalization Risk with LDL by CKD Stage in African-American and White US Veterans	8
Early impact of 2018 AHA/ACC/Multisociety Cholesterol Guideline on lipid monitoring after statin initiation	8
Fellow Quality Improvement Project: Identification of High Risk CAD Patients and Referral to Newly Established Lipid Clinic, What are the Clinical Implications?	8
CAC Scoring as an Index for Subclinical Carotid Atherosclerosis	8
Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye	8
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Pre	8
Novel PPARG mutation in multiple family members with chylomicronemia	8
Effect of pharmacologic anti-atherosclerotic therapy on carotid intraplaque neovascularization: A systematic review	8
Dysbetalipoproteinamia: Implications for Pre-Conception, Pregnancy and Beyond	8
Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects	8
From the editor: Heroes in a historic time	8
Differences in Clinical outcomes between Non-Obese Hispanic and Asian populations Who have Hyperlipidemia	8
Association between very high HDL-C levels and mortality: A systematic review and meta-analysis	8
Spotlight on Abetalipoproteinemia and Related Hypobetalipoproteinemia Disorders: A Simplified Nomenclature and Clinical Guidelines. †	8
Table of Contents	8
From the editor: Lipidology resurgent as the pandemic wanes	7
Equitable Access to Screening and Lipid-Lowering Therapies in a Large Academic Center after Educational Interventions	7
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease	7
A novel homozygous nonsense variant of LMF1 in pregnancy-induced hypertriglyceridemia with acute pancreatitis	7
Validation of physical examinations of tendon xanthomas and changes in the cutoff values of Achilles tendon thickness on radiography in the clinical criteria of heterozygous familial hypercholesterole	7
Differences in treatment strategies for LDL-cholesterol reduction in a university lipid clinic vs. standard care apart from the use of PCSK9 inhibitors	7
Differences in Clinical Outcomes between Non-Obese African American and Asian Populations Who have Hyperlipidemia	7
No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized control	7
Modifications on lipid profile and high-density lipoprotein function related to treatment with tofacitinib in female patients with rheumatoid arthritis: Impact of previous therapy with biological agen	7
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States	7
Lipoprotein(a): Mirroring Familial Hypercholesterolemia	7
Elevated Serum Small Dense Low Density Lipoprotein Cholesterol and Lipoprotein(a) Levels in Preeclampsia	7
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial	7
Assessment of lipid-lowering therapies in high-risk patients with inflammatory joint diseases—Insights from a preventive cardio-rheuma clinic	7
Hyperlipidemia and risk for preclampsia	7
†Food Compass Score is Inversely Related to Inflammatory Markers and Cardiovascular Disease Incidence: Results from the ATTICA Cohort Study (2002-2022)	6
Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults	6
Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses	6
In memoriam, Avedis Khachadurian 1926 - Sept 22,2022	6
JCL Roundtable. Making prevention a priority	6
Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia	6
Editorial Board	6
Carotid sheath xanthoma: A rare manifestation of lipid disorders	6
Remnant cholesterol as a residual risk in atherosclerotic cardiovascular disease patients under statin-based lipid-lowering therapy: A post hoc analysis of the RACING trial	6
In memoriam: A tribute to Dr Scott M. Grundy	6
What's next for lipoprotein(a)? A National Lipid Association report from an Expert Panel Discussion	6
Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome	6
Genomic study of maternal lipid traits in early pregnancy concurs with four known adult lipid loci	5
Negative LDL-C levels with Detectable Apolipoprotein B: Surrogate Markers of Atherosclerotic Disease and Cardiac Event Risk	5
†Efficacy and Safety of Bempedoic Acid in Patients with Metabolic Syndrome	5
Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study	5
Moderate Alcohol Consumption and Lipoprotein Subfractions: A Systematic Review of Intervention and Observational Studies	5
+Racial Inequities in Coronary Artery Calcium Screening and Follow-up	5
*A Novel ABCG8 Variant and Apo(A) Short Isoform Associated with Premature Atherosclerosis and Familial Hypercholesterolemia Phenocopy.	5
Treatment Target Achievement in Patients with Familial Hypercholesterolemia: A Real-World Descriptive Study	5
^Sex Disparities in the Treatment and Outcomes of Familial Hypercholesterolemia	5
From the editor: A compendium of lipidology progress	5
The Food Compass Score is Negatively Related to the Activity of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Healthy Adults.	5
† Higher Cardiovascular Event Rates for High-Risk Americans Who Did Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds	5
Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia	5
CME Activity Highlights the Improvement in Clinician's Knowledge and Competence about Treatment Choices for LDL-C Lowering Post-MI	4
Detailed Family History of Premature Atherosclerotic Cardiovascular Disease to Guide Lipoprotein(a) Testing: The Multi-Ethnic Study of Atherosclerosis	4
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table	4
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	4
Disparities in access to pharmacotherapies for weight loss and cardiovascular prevention	4
Improving cholesterol management in high-risk primary prevention patients: An evidence-based case series	4
Successful pregnancy outcome in a woman with cholesteryl ester storage disease treated with enzyme replacement therapy	4
Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor	4
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center	4
Diagnosis and Management of Familial Dysbetalipoproteinemia in a Patient with Apo E2/E2 Genotype	4
Severe Hypertriglyceridemia as a Cause of Arterial Thrombosis with Peripheral Embolic Complications.	4

†Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-human Primates	4
Identification of High Cardiovascular Disease Risk Individuals in an Underserved Patient Population Clinic	4
Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipid	4
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	4
Editorial Board	4
Comprehensive analysis of Chinese patients with non-LPL familial chylomicronemia syndrome: Genetic variants, dietary interventions, and clinical insights	4
Oral semaglutide and reduction in major adverse cardiovascular events	4
Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine	4
Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania Health System	4
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients	4
Pegylated-Asparaginase Induced Severe Hypertriglyceridemia in an Adult with Acute B-cell Lymphoblastic Leukemia	4
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial	4
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study	4
Racial Variations in SGLT2 Inhibitor Prescriptions	4
The Analysis of the Breakpoint of Large Rearrangements of LDLR Gene in a Taiwanese Cohort of Patients with Familial Hypercholesterolemia	4
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results	4
Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer	4
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice	4
Impact of conducting a genetic study on the management of familial hypercholesterolemia	4
Corrigendum to Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association [Journal of Clinical Lipidology Volume 13, Issue	4
A case of lipoprotein glomerulopathy due to the pathogenic APOE Las Vegas variant c.509C > A: p. (Ala170Asp)	4
Timing of PCSK9i Initiation and Its Relationship with Clinical Outcomes in US Patients with Prior Cardiovascular Events: A Claims Database Analysis	4
Unveiling Compound Heterozygous Familial Hypercholesterolemia	4
Use of commercial genetic testing to help reclassify LDL receptor variants in clinical practice: A case report	3
Unfavorably altered lipid profile in women with primary ovarian insufficiency	3
From the editor: From a hell of a year to “Hello Telemedicine”	3
Association of Systemic Inflammation with Lipid Profiles and Management in Patients with Rheumatoid Arthritis	3
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction	3
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia	3
Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome	3
Statin therapy for primary prevention in women: What is the role for coronary artery calcium?	3
Eicosapentaenoic Acid Reverses Endothelial Dysfunction following Exposure to the Cytokine IL-6 in Contrast to Docosahexaenoic and Arachidonic Acids	3
Acknowledgement of Referees	3
Case Report - Lysosomal Acid Lipase Deficiency - A Rare Cardiometabolic Disease and a NAFLD Mimic	3
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins	3
Rare genetic cerebrotendinous xanthomatosis (CTX) cases without cholestanol elevation but with prominent cholesterol-rich tendon xanthomas	3
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis	3
Ordering Trends and Report Outcomes for Lipid Genes on a Comprehensive Cardiovascular Genetics Menu	3
The Outcome of Percutaneous Coronary Intervention in Prediabetes Patients: A Nationwide Analysis	3
†Obicetrapib Treatment Increases Pre-Beta1 HDL and Lipophilic Antioxidants in the Ocean and Rose2 Studies	3
Association between remnant cholesterol and culprit vessel physiological features in patients with acute coronary syndrome: An optical coherence tomography study	3
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over ten years of efficacy and safety data	3
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)	3
Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)	3
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research	3
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3	3
News from NLA	3
Time-Averaged LDL-C Lowering with Evolocumab: Pooled Analysis of Phase 2 Trials	3
Circulating Levels of PCSK9, ANGPTL3 and Lp(a) in Stage III Breast Cancers	3
Patients with Dyslipidemia and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study	3
Development of a Clinical Diagnostic Score for Familial Chylomicronemia Syndrome (FCS)	3
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia	3
Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study	3
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching	3
A Qualitative Study to Explore the Patient Experience of Hypertriglyceridemia-related Acute Pancreatitis	3
Assessing omega-3 fatty acids–critically weighing options and relevance	3
⁎ A Genome-First Approach to Identify Carriers of Familial Hypercholesterolemia Causing variants	2
Novel Use of Therapeutic Plasma Exchange and Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia	2
From the editor: Coyotes on the lawn	2
Process Mapping the Lipid Management Patient Pathway in Six Health Systems for Identification of Barriers to Guideline-Directed Care	2
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association	2
Familial Hypercholesterolemia Diagnosis and Management: Insights from the NIH Precision Medicine Initiative All of Us Study	2
JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating	2
The Value of Lipid Testing in Recognizing Residual Risk	2
From the Editors: New concepts in obesity and cardiovascular disease	2
The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia	2
A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency	2
Identification of a homozygous variant in ABCG5 by panel sequencing in a Pakistani family with sitosterolemia: Genotype-phenotype correlation and management considerations	2
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India	2
†Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled Post hoc Analysis of the phase 3 ORION-9, ORION-10, and ORION-11 Randomized Controlled Trials	2
†A Cross-Study Comparison Investigating the Effect of CSL112 (Apolipoprotein A-I [Human]) on Cholesterol Efflux Capacity (Encore ACC 2022)	2
Effects of Music Therapy on Psychological Constructs and Atherogenic Lipoproteins in Patients with Severe Hypercholesterolemia	2
Impact of Familial Hypercholesterolemia on Coronary Artery Dissection in Patients Undergoing Percutaneous Coronary Intervention (PCI)	2
Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model	2
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia	2
Prevalence, pattern, and correlates of dyslipidemia in Bangladeshi individuals	2
News from NLA	2
Multiple Myeloma and Hyperlipidemia - coincidence or related?	2
Success of Online CME at Improving Knowledge and Confidence on Interdisciplinary Management of Dyslipidemia	2
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study	2
Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations	2
A Patient who is Nonresponsive to PSCK9 Inhibition by both mAb and RNAi	2
Interlaboratory comparison of serum lipoprotein(a) analytical results across clinical assays—Steps toward standardization	2
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion	2
Cardiometabolic risk factors in young adults with acute myocardial infarction.	2
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran	2
Dietary recommendations for dysbetalipoproteinemia: A need for better evidence	2
Mediation effect of metabolic factors and inflammation on the association of serum uric acid with serum proprotein convertase subtilisin/kexin type 9 levels	2
†Real-World Effectiveness and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: A Multi-site US Perspective	2
High burden of disease in patients with homozygous familial hypercholesterolemia despite recent advances in therapies and updated guidelines: A real-world study	2
*Pericardial and Pleural Effusions after Evolocumab in a Patient with Severe Familial Hypercholesterolemia	2
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	2
Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey	2
Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review	2
Akira Endo (1933–2024), in memoriam	2